Everyday Health on MSN
Why Blood Sugar Matters for Heart Health Even if You Don’t Have Diabetes
Learn why even slightly elevated blood sugar levels can put your heart at risk and how simple lifestyle changes can protect your cardiovascular health.
A recent mouse study suggests that low-oxygen conditions, such as being at high altitudes, could cause red blood cells to absorb excess blood glucose, potentially helping to protect against diabetes.
Replacing soda with sparkling water can help lower blood sugar by cutting added sugar and supporting better glucose control over time.
My doctor put me on a glucose monitor to track my blood sugar for a few weeks. There were three nights when my husband and I went walking after dinner, and those readings were better. He thinks it’s ...
If you're looking for ways to mitigate your risk of developing cardiovascular disease or experiencing a cardiac event, such as a heart attack or stroke, glucagon-like peptide-1 (GLP-1) ...
Brianna Tobritzhofer is a nationally credentialed Registered Dietitian and experienced health writer with over a decade of leadership in nutrition program development, policy compliance, and public ...
Jillian Kubala, MS, is a registered dietitian based in Westhampton, NY. Jillian uses a unique and personalized approach to help her clients achieve optimal wellness through nutrition and lifestyle ...
Every time Gabby publishes a story, you’ll get an alert straight to your inbox! Enter your email By clicking “Sign up”, you agree to receive emails from ...
Our Real Talk with a Doc columnist explains how to push back if your doctor's obsessed with weight loss. And what other health metrics matter more instead.
Arabian Post on MSN
Triple agonist UBT251 delivers up to 19.7% mean weight loss after 24 weeks in phase 2 trial in China
UBT251 is a triple agonist of the receptors for GLP-1, GIP and glucagon (triple G), being jointly developed by United Biotechnology and Novo Nordisk In a placebo-controlled phase 2 trial in Chinese ...
Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases ...
Accessing PHI for development and testing is often blocked by stringent HIPAA compliance requirements. Learn how synthetic data helps engineers build tools to close care gaps and improve HEDIS scores.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results